4D Bioprinting Innovation Network
We are pleased to be a part of this innovation network which aim is to support concrete innovative products and new services in the field of bioprinting for applications in biology, pharmacy, and medicine. The network promotes the commercialization of the innovative technologies of the network partners by market-oriented R&D projects and establishment of new value chains for biopharmaceuticals and medicine.
The aim of the network is the initiation, concept development and application for funding for research and development projects of the network partners in the fields of sensors/automation, innovative bio-inks and the inclusion of time as a fourth dimension that enables innovative applications and end products. This results in an economically relevant contribution to a sustainable and personalized medicine.
Life Science Nord is committed to innovative medicine in Hamburg and Schleswig-Holstein. Within the regional cluster for medical technology and biotechnology/pharma there are 42,300 emplyees working for about 500 innovation-oriented companies. In 2014, the industry generated a gross value of 4,0 bn Euro and the cluster's exports were 5,8 bn Euro. Additionally, the region hosts internationally renowned research institutes, universities and university clinics. Together they represent the entire value chain necessary for the emergence of new treatments and medical devices: from research, development and clinical studies, to manufacturing, marketing and sales. Life Science Nord strengthens this regional industry and is a visible entity on the European stage.